Kimberly-Clark and Kenvue: Two Giant Partnerships

Kimberly-Clark Corporation (NASDAQ:KMB) has recently become one of the important stocks highlighted by Jim Cramer. Cramer also brought attention to these shares after announcing that the company would acquire Kenvue, a producer of personal and household products, for $48.7 billion.

Cramer evaluated Kimberly-Clark's CEO and the reasoning behind this acquisition, stating, "I love this deal. Because I think Kenvue is weak in areas where Kimberly-Clark is strong; especially in China. The opposite is true in Europe. Kimberly-Clark has a strong understanding of data and demonstrates that Tylenol has not weakened with any of the issues the government has discussed. Additionally, I should mention that lawsuits concerning pregnant women have not been very effective in Europe due to the separation from Johnson & Johnson. There, the punitive laws are not so strict and large damages are not being sought. This situation reflects poorly on the deal, but it's actually not that bad."

While seeing Kimberly-Clark's potential as an investment opportunity, we believe that some artificial intelligence stocks hold more promise for higher returns. If you are looking for a very cheap artificial intelligence stock and wish to discover a stock that will benefit greatly from Trump tariffs and domestic production, you can find more information.